Evidence map›Paper›PMID 29747875›Full record

ArticleAddictive behaviors2018

Young adults' opioid use trajectories: From nonmedical prescription opioid use to heroin, drug injection, drug treatment and overdose.

Honoria Guarino, Pedro Mateu-Gelabert, Jennifer Teubl, Elizabeth Goodbody

Open access · greenAbstract read
In one paragraph

Article in Addictive behaviors, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Honoria GuarinoInstitute for Infectious Disease Research, National Development and Research Institutes (NDRI), 71 W. 23rd St., 4th Fl., New York, NY 10010, USA. Electronic address: guarino@ndri.org.
Pedro Mateu-GelabertInstitute for Infectious Disease Research, National Development and Research Institutes (NDRI), 71 W. 23rd St., 4th Fl., New York, NY 10010, USA. Electronic address: mateu-gelabert@ndri.org.
Jennifer TeublInstitute for Infectious Disease Research, National Development and Research Institutes (NDRI), 71 W. 23rd St., 4th Fl., New York, NY 10010, USA; Sackler Institute of Graduate Biomedical Sciences, New York Langone Medical Center, 550 First Avenue, New York, NY 10016, USA. Electronic address: jrteubl@gmail.com.
Elizabeth GoodbodyInstitute for Infectious Disease Research, National Development and Research Institutes (NDRI), 71 W. 23rd St., 4th Fl., New York, NY 10010, USA. Electronic address: goodbody@ndri.org.
National Development and Research Institutes · USNYU Langone Health · US

Funding

The Staying Safe Intervention: Preventing HCV among Young Opioid InjectorsR01DA041501 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI GUARINO, HONORIA M, MATEU-GELABERT, PEDRO · 2016 to 2020
$3.6M
HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription OpioidsR01DA035146 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI MATEU-GELABERT, PEDRO · 2013 to 2017
$2.9M
NIDA NIH HHS R01 DA035146NIDA NIH HHS R01 DA041501
6 · The paper itself

Abstract

introductionRecent research has begun to explore the transition from nonmedical use of prescription opioids (POs) to heroin and injection drug use, adding to earlier literature identifying factors that influence the transition from intranasal to injection use of heroin. However, little research has explored how these transitions are embedded within young people's broader opioid use trajectories - individual pathways that may also include experiences of nonfatal overdose and drug treatment.

methodsData are from a study of 539 18-29 year-old New York City residents, recruited via Respondent-Driven Sampling, who reported past-month nonmedical use of POs and/or heroin use. Participants completed structured, computer-assisted interviews that included assessment of their ages at a series of "benchmark" events and experiences, including first use of a drug or route of administration, the onset of "regular" use of a drug (i.e., 1 or more times a week for at least 1 month), first overdose and first drug treatment.

resultsResults suggest a predictable, ordered pathway by which opioid use tends to progress in this cohort of young adults. Participants initiated nonmedical PO use at age 16.8, on average, and most transitioned to heroin use (83%) and heroin injection (64%), generally within 4 years of first PO misuse. Drug treatment was not typically accessed until after participants had progressed to heroin use. First overdose occurred <1 year after first heroin use, on average.

conclusionsFindings may help inform the optimal timing for delivery of primary, secondary and tertiary prevention efforts targeting young opioid users.

Indexed as

AdolescentAdultDisease ProgressionDrug OverdoseHeroin DependenceHumansNew York CityOpioid-Related DisordersPrescription Drug MisuseSubstance Abuse, IntravenousYoung AdultDrug transitionsHeroinInjection drug useNonmedical prescription opioid useOpioid use trajectoriesYoung adults

Identifiers

PMID29747875
PMCPMC6377245
OpenAlexW2800010706

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.